ID   NBT-T2
AC   CVCL_4675
DR   CLO; CLO_0050838
DR   RCB; RCB1370
DR   Wikidata; Q54907567
RX   PubMed=9369930;
RX   PubMed=29732388;
CC   Characteristics: Forms tight colonies and exhibited very low or negligible invasive activity (PubMed=9369930).
CC   Doubling time: 12.8 hours (PubMed=9369930).
CC   Transformant: ChEBI; CHEBI:91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: Wistar.
DI   NCIt; C60691; Rat urinary system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0453 ! NBT-II
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
RX   PubMed=9369930; DOI=10.1111/j.1349-7006.1997.tb00458.x;
RA   Nishi N., Inui M., Kishi Y., Miyanaka H., Wada F.;
RT   "Isolation and characterization of invasive and noninvasive variants
RT   of a rat bladder tumor cell line.";
RL   Jpn. J. Cancer Res. 88:831-838(1997).
//
RX   PubMed=29732388; DOI=10.3233/BLC-180167;
RA   Zuiverloon T.C.M., de Jong F.C., Costello J.C., Theodorescu D.;
RT   "Systematic review: characteristics and preclinical uses of bladder
RT   cancer cell lines.";
RL   Bladder Cancer 4:169-183(2018).
//